Daptomycin: a novel agent for Gram-positive infections

Author： Tally F.P.   Zeckel M.   Wasilewski M.M.   Carini C.   Berman C.L.   Drusano G.L.   Oleson F.B.  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.8, Iss.8, 1999-08, pp. : 1223-1238

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Daptomycin - a novel antibacterial in the fight against resistant Gram-positive infections

By  

Inpharma, Vol. 1, Iss. 1286, 2001-01 ,pp. : 10-11

Adis International

Access to resources Recommend Favorite

Daptomycin - a new option for resistant Gram-positive infections

By  

Inpharma, Vol. 1, Iss. 1342, 2002-01 ,pp. : 9-11

Adis International

Access to resources Recommend Favorite

Lipopeptides, focusing on daptomycin, for the treatment of Gram-positive infections

By Eisenstein Barry I  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 9, 2004-09 ,pp. : 1159-1169

Informa Healthcare

Access to resources Recommend Favorite

`Synercid' - a novel agent for severe multiresistant Gram-positive infections

By  

Inpharma, Vol. 1, Iss. 1227, 2000-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Daptomycin – a novel antibiotic against Gram-positive pathogens

By LaPlante Kerry L   Rybak Michael J  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 11, 2004-11 ,pp. : 2321-2331

Informa Healthcare

Access to resources Recommend Favorite